We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endoscope Protection System Prevents Accidental Laser Damage

By HospiMedica staff writers
Posted on 13 Nov 2007
An endoscope protection system (EPS) has been designed to prevent accidental laser damage to the distal end of flexible ureteroscopes from holmium lasers.

The Gyrus EPS is used in conjunction with the Gyrus DUR-D Digital Flexible Ureteroscope. More...
An ultra-miniature (1 mm) complementary metal oxide semi-conductor (CMOS) distal sensor technology works in unison with the Gyrus EPS software to accurately detect the laser fiber position, and instructs the laser to shutdown when the fiber is withdrawn to a position inside the working channel of the endoscope where damage could occur. The EPS response is based on feedback from the CMOS imaging chip at the distal end of the DUR-D Ureteroscope.

The EPS software package provides two modes of operation. The Alert Only mode accurately detects the laser fiber position and emits an alert tone and Check-Fiber warning message on the monitor screen. In the Control Laser mode, the DUR-HL20 laser is connected to the control unit and can be actively fired if the laser fiber is in the safe field of view. If the laser fiber is retracted too far into the ureteroscope, the software emits the alert tone, flashes a Check Fiber warning, and places the laser in its standby mode. Shutdown of the laser occurs in less than 100 milliseconds and the laser cannot be fired again until the fiber is advanced to a safe distance and the laser is put into its ready mode. In trials, even after 120 laser fiber retractions into the DUR-D Ureteroscope while actively firing, there was no evidence of damage and ureteroscope performance remained unchanged. All these products are manufactured by Gyrus ACMI (Southborough, MA, USA.com).

"Surgeons use ureteroscopes to access, diagnose and treat almost all upper urinary tract conditions. Considering that up to 70% of ureteroscope malfunction can be attributed to laser damage, the Gyrus ACMI Endoscope Protection System (EPS) is an important technology advancement that will dramatically decrease the number of repairs and reduce the cost of doing ureteroscopy”, said Roy Davis, CEO of the Gyrus Group.


Related Links:
Gyrus ACMI

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.